Skip to content
Screener

Bausch Health Companies BHC Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Ardelyx logo
ArdelyxARDX
$6.5M-8.0%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$3.87M-24.8%
Bausch + Lomb logo
Bausch + LombBLCO
Staar Surgical logo
Staar SurgicalSTAA
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.34B+11.7%
Enterprise value$21.79B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemMarch 31,2026December 31,2025
Intangible assets, net4,4044,643
Goodwill9,80711,271
Deferred tax assets, net1,8451,843
Other non-current assets369378
Total assets$24,498$26,366
Liabilities
Current liabilities:
Accounts payable$593$600

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's deferred tax assets and other non-current assets?
Bausch Health Companies (BHC) reported deferred tax assets and other non-current assets of $369M in Q1 2026.
How has Bausch Health Companies's deferred tax assets and other non-current assets changed year-over-year?
Bausch Health Companies's deferred tax assets and other non-current assets decreased by 2.9% year-over-year, from $380M to $369M.
What is the long-term trend for Bausch Health Companies's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Bausch Health Companies's deferred tax assets and other non-current assets has grown at a -10.7% compound annual growth rate (CAGR), from $664M to $378M.

Ask your AI about Bausch Health Companies's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude